U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. Clinical Outcome Assessment (COA) Qualification Program
  6. DDT COA #000125: Endurance Shuttle Walking Test (ESWT)
  1. Clinical Outcome Assessment (COA) Qualification Program

DDT COA #000125: Endurance Shuttle Walking Test (ESWT)

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Immunology and Inflammation (OII)
Division of Pulmonary, Allergy, and Critical Care (DPACC)

DDT COA Number
DDT COA #000125

Instrument Name
Endurance Shuttle Walking Test (ESWT)

Disease/Condition
Chronic Obstructive Pulmonary Disease (COPD)

Concept of Interest
Walking endurance

Context of Use
Patients with COPD

COA Type
PerfO

Qualification Stage
Qualification Plan - Not Accepted

Requestor(s)
COPD Biomarker Qualification Consortium (CBQC)

Contact(s)
Debora Merrill

Date Accepted into CDER’s COA Qualification Program
May 14, 2015

Submission and Regulatory Correspondence History

Qualification Submission Date FDA Submission Decision & Recommendations Date
Qualification Plan 5/4/20 FDA Response (Not Accepted) 10/20/20
Back to Top